Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia

Clinical trial NCT06650488 · RECRUITING

Trial details

NCT number: NCT06650488
Sponsor: Todd C. Lee MD MPH FIDSA
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Staphylococcus Aureus Endocarditis Staphylococcus Aureus Septicemia Staphylococcus Aureus Bloodstream Infection

Start date: 2026-01-15
Primary completion: 2030-01-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.